Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 196

3.

Mood stabilizer valproate promotes ERK pathway-dependent cortical neuronal growth and neurogenesis.

Hao Y, Creson T, Zhang L, Li P, Du F, Yuan P, Gould TD, Manji HK, Chen G.

J Neurosci. 2004 Jul 21;24(29):6590-9.

4.

The use of mood stabilizers as plasticity enhancers in the treatment of neuropsychiatric disorders.

Gray NA, Zhou R, Du J, Moore GJ, Manji HK.

J Clin Psychiatry. 2003;64 Suppl 5:3-17. Review.

5.

Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2's neurotrophic effects?

Moore GJ, Bebchuk JM, Hasanat K, Chen G, Seraji-Bozorgzad N, Wilds IB, Faulk MW, Koch S, Glitz DA, Jolkovsky L, Manji HK.

Biol Psychiatry. 2000 Jul 1;48(1):1-8.

PMID:
10913502
6.

A longitudinal study of the effects of lithium treatment on prefrontal and subgenual prefrontal gray matter volume in treatment-responsive bipolar disorder patients.

Moore GJ, Cortese BM, Glitz DA, Zajac-Benitez C, Quiroz JA, Uhde TW, Drevets WC, Manji HK.

J Clin Psychiatry. 2009 Apr 21;70(5):699-705. doi: 10.4088/JCP.07m03745.

PMID:
19389332
7.

Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications.

Manji HK, Bebchuk JM, Moore GJ, Glitz D, Hasanat KA, Chen G.

J Clin Psychiatry. 1999;60 Suppl 2:27-39; discussion 40-1, 113-6. Review.

8.

The antiapoptotic actions of mood stabilizers: molecular mechanisms and therapeutic potentials.

Chuang DM.

Ann N Y Acad Sci. 2005 Aug;1053:195-204. Review.

PMID:
16179524
10.

The role of the extracellular signal-regulated kinase signaling pathway in mood modulation.

Einat H, Yuan P, Gould TD, Li J, Du J, Zhang L, Manji HK, Chen G.

J Neurosci. 2003 Aug 13;23(19):7311-6.

11.

Chronic treatment with lithium, but not sodium valproate, increases cortical N-acetyl-aspartate concentrations in euthymic bipolar patients.

Silverstone PH, Wu RH, O'Donnell T, Ulrich M, Asghar SJ, Hanstock CC.

Int Clin Psychopharmacol. 2003 Mar;18(2):73-9.

PMID:
12598817
12.

The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS.

Chen G, Zeng WZ, Yuan PX, Huang LD, Jiang YM, Zhao ZH, Manji HK.

J Neurochem. 1999 Feb;72(2):879-82.

13.

[Neuroprotective actions of lithium].

Hashimoto R, Fujimaki K, Jeong MR, Senatorov VV, Christ L, Leeds P, Chuang DM, Takeda M.

Seishin Shinkeigaku Zasshi. 2003;105(1):81-6. Review. Japanese.

PMID:
12701214
14.

Signalling pathways in the brain: cellular transduction of mood stabilisation in the treatment of manic-depressive illness.

Manji HK, McNamara R, Chen G, Lenox RH.

Aust N Z J Psychiatry. 1999 Dec;33 Suppl:S65-83. Review.

PMID:
10622182
15.

Valproate and neuroprotective effects for bipolar disorder.

Atmaca M.

Int Rev Psychiatry. 2009;21(4):410-3. doi: 10.1080/09540260902962206. Review.

PMID:
20374154
16.

The anti-apoptotic, glucocorticoid receptor cochaperone protein BAG-1 is a long-term target for the actions of mood stabilizers.

Zhou R, Gray NA, Yuan P, Li X, Chen J, Chen G, Damschroder-Williams P, Du J, Zhang L, Manji HK.

J Neurosci. 2005 May 4;25(18):4493-502.

18.

Mood-stabilizing drugs: are their neuroprotective aspects clinically relevant?

Lagace DC, Eisch AJ.

Psychiatr Clin North Am. 2005 Jun;28(2):399-414. Review.

PMID:
15826739
19.

[Predictors of prophylactic response to lithium].

Rohayem J, Baylé JF, Richa S.

Encephale. 2008 Sep;34(4):394-9. doi: 10.1016/j.encep.2007.05.002. Epub 2007 Nov 26. Review. French.

PMID:
18922242
20.

Supplemental Content

Support Center